The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
-
Int. J. Tuberc. Lung Dis. · Oct 2011
Comparative StudyUse of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease.
Serum biomarkers are rarely studied in patients with non-tuberculous mycobacterial lung disease (NTM-LD). ⋯ In patients with respiratory specimens that are culture-positive for NTM with clinical suspicion of NTM-LD, serum sTREM-1 level measurements may be helpful in diagnosing and predicting outcome for NTM-LD.
-
Int. J. Tuberc. Lung Dis. · Oct 2011
Screening and follow-up of children exposed to tuberculosis cases, Luanda, Angola.
This prospective study enrolled children aged < 5 years with reported contact with adult tuberculosis (TB) patients in Angola. The study sample consisted of 124 children: 70 (56.5%) were active TB cases, 22 (17.7%) had latent TB infection (LTBI) and 32 (25.8%) were TB-exposed; 14 (20%) were human immunodeficiency virus positive. After 6 months of follow-up, 31.8% of the LTBI cases had evolved to active TB and 9.4% of the non-infected children had developed active TB. The strategy of simultaneous chest X-ray and TB skin test used in this study was effective; despite this protocol, however, 31.8% LTBI children developed active TB.
-
Int. J. Tuberc. Lung Dis. · Oct 2011
Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India.
Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases (LRS), a tertiary level tuberculosis (TB) institute in Delhi, India. ⋯ The majority of contacts of MDR-TB patients had drug-susceptible TB and the rate of MDRTB was very low. Evaluation of contacts of MDR-TB cases may lead to early diagnosis and prevention of TB.
-
Int. J. Tuberc. Lung Dis. · Sep 2011
Meta AnalysisAttributable mortality of ventilator-associated pneumonia: a meta-analysis.
To investigate whether ventilator-associated pneumonia (VAP) is a true cause of mortality in the intensive care unit setting. ⋯ Presence, compared to absence, of VAP seems to be associated with higher mortality in critically ill patients. Appropriateness of initial antimicrobial treatment in such patients may moderate this association.